It could be a promising molecule for colon cancer treatments, given its capability of reducing cell growth, arresting the cell cycle in G1 phase, and inducing the apoptosis by the activation of caspase-3 and -9, with a critical impact on EGFR/ERK and EGFR/Akt signaling pathways [162,163]. The gene discussed is AKT1; the disease is colonic neoplasm.